WHAT DOES TRASTUZUMAB ANNS MEAN?

One of the more underneath-investigated “driving forces” associated with trastuzumab resistance is PTEN. Nagata et al. (2004) reported the loss of PTEN was observed in 36% of HER2-positive Principal breast tumor specimens from individuals with phase IV disease. On top of that, In addition they confirmed that individuals with PTEN-deficient tumo